Subsequently, we performed Western blots to assess the protein level of amyloid precursor protein (APP) and β-site APP cleaving enzyme-1 (BACE1) in the hippocampus, a phenomenon associated with cognitive impairment [32,33]. This evidence concerns the gene APP and Cognitive impairment.